<DOC>
	<DOCNO>NCT00588198</DOCNO>
	<brief_summary>The purpose study determine tumor cell detect peripheral blood and/or bone marrow patient melanoma .</brief_summary>
	<brief_title>Peripheral Blood and/or Bone Marrow , Including Detection Occult Metastases , Patients With Melanoma</brief_title>
	<detailed_description>Patients melanoma succumb subclinical metastatic disease , detectable presentation conventional physical examination , hematologic biochemical screening , radiologic evaluation . More intensive radiologic evaluation CT radioisotope scan proven useful . What may useful sensitive method stag melanoma patient presentation , specifically evaluate subclinical systemic disease .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>MSK Patients histologically confirm melanoma site least one following : Primary tumor &gt; 4.0 mm thick ( AJCC Stage IIB ) Clinically histologically positive regional node ( AJCC Stage III ) Any transit disease ( AJCC Stage III ) Any systemic metastasis ( AJCC Stage IV )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>histologically confirm melanoma site</keyword>
</DOC>